The US Department of Health & Human Services Agency for Healthcare Research and Quality (AHRQ) has awarded Thomas G. McGinn, MD, MPH, with a three-year, $1.14 million grant for a clinical decision support (CDS) system that reduces frontline providers’ complications and frustrations.
| MANHASSET, N.Y., April 10, 2019 /PRNewswire/ -- The US Department of Health & Human Services Agency for Healthcare Research and Quality (AHRQ) has awarded Thomas G. McGinn, MD, MPH, with a three-year, $1.14 million grant for a clinical decision support (CDS) system that reduces frontline providers’ complications and frustrations. While clinical decision support has been widely available for years, healthcare providers have not adopted it widely because the systems are unwieldy and time-consuming for practitioners who are trying to access personalized clinical information and guidance in the real-time setting of patient encounters.
For more than a decade, Dr. McGinn, Feinstein Institute for Medical Research professor and Northwell Health senior vice president and deputy physician-in-chief, and his team at the Feinstein Institute’s Center for Health Innovations and Outcomes Research (CHIOR) have been studying, testing, and disseminating CDS in electronic health records. They focus on clinical prediction rules (CPRs), a form of CDS that uses a variety of data, mechanisms, and patient-specific information to calculate patient-specific probabilities. CPRs increase diagnostic accuracy, reduce unnecessary testing and treatment, and enhance quality and safety. To date, however, critical variations in electronic health record systems between and even within institutions have severely limited dissemination of CDS and its adoption into provider workflow. The CDS system under development by CHIOR builds on widely validated CPRs for detecting blood clots in the lungs and for bleeding risk in hospitalized patients. The system’s ability to impact care in emergency medicine and inpatient medical care settings will be assessed. “When available at the point of care, clinical decision support allows physicians to blend medical acumen and evidence in real time,” said Dr. McGinn, who also oversees Northwell’s medicine programs and service line. “With AHRQ’s support, we can design a system that targets and triggers the appropriate clinical prediction rules for the right people, at the right moment, incorporating patient-specific information and bringing evidence-based medicine directly to the point of care.” In December 2018, Safiya Richardson, MD, MPH, an assistant professor at the Zucker School of Medicine at Hofstra/Northwell and junior faculty researcher at the Feinstein Institute mentored by Dr. McGinn at CHIOR, was awarded a five-year grant from the National Institutes of Health to support her work in creating tools that help doctors make evidence-based clinical decisions. In the project’s initial phase, Dr. Richardson will develop tool prototypes and test these with doctors. “Evidence based medicine is the best medicine,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institute. “Dr. McGinn’s work advances this field by using the vast clinical information technology here at Northwell.” Dr. McGinn will be working closely with his co-investigators, including Sundas Khan, MD, administrative manager for research, and Jeffrey Solomon, Northwell’s director of project clinical information systems. Northwell’s key internal collaborators will include Michael Oppenheim, MD, VP and chief medical information officer, and John Chelico, MD, chief research information officer. This project is funded under grant number R18 HS 026196 from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services. About the Feinstein Institute for Medical Research About Northwell Health
SOURCE The Feinstein Institute for Medical Research |
View original content to download multimedia:
